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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S117Conclusions: Abnormally increased mechanical stress due to varus
deformity was associated with cartilage degradation. Interestingly,
chondrocytes in MA were mainly cluster with STRO-1, Ki67 and FGF2
expression. Excessive mechanical stress in MAmay induce chondrocyte
proliferation by FGF2 and high turnover. On the contrary, reduction of
mechanical stress at LC due to varus deformity resulted in low-density
of chondrocytes that seemed to reduce proliferative and biosynthetic
activity. Chondrocytes especially in adjacent of degenerated cartilage
formed cluster with proliferative and immature character, and may still
have the self-repair potential such an end stage of OA knee.Figure 1. STRO-1, Ki67 and FGF2 expression in MA and LC. MA expressed STRO-1,
Ki67 and FGF2 rather than LC. Safranin O (A.E). STRO-1 (B,F), Ki-67 (C,G), and FGF2
(D,H) (Original magniﬁcation x100 in A, B, C, D, E, F, G, H).
Figure 2. Toluisin blue staining with chondrocytes from MA and LC. MA made
cartilage like nodules more than LA rapidly.208
MOLECULAR INSIGHT INTO THE ASSOCIATION BETWEEN CARTILAGE
REGENERATION AND EAR WOUND HEALING IN GENETIC MOUSE
MODELS: TARGETING NEW GENES IN REGENERATION
M.F. Rai, A. McAlinden, J.M. Cheverud, L.J. Sandell.Washington Univ. Sch.
of Med., St. Louis, MO, USA
Purpose: Tissue regeneration is a complex genetic trait. We have
identiﬁed mouse strains with varying potential to heal through-and-
through ear wounds and to regenerate full-thickness knee articular
cartilage lesions. Using the recombinant inbred strains generated from
the LG/J and SM/J intercross, a strong positive correlation between the
two phenotypes implicated that similar set of genetic components
might orchestrate regenerative processes in ear tissues and knee
articular cartilage. However, our understanding of the genes that govern
the regenerative process is limited.Methods. To identify common gene(s) driving the sequential regener-
ative process, we used recombinant inbred strains (as opposed to
common inbred strains such as C57BL/6) because they provide power to
differentiate phenotypic differences due to genetic variation. Here, we
analyzed strain differences through gene expression analysis with
QuantiGene Plex assay using archived mouse tissues. Sixty-seven
candidate genes known to be involved in a wide-array of common
biological processes and six microRNAs were quantiﬁed in six related
recombinant inbred strains.
Results. The expression of nineteen genes and all microRNAs was found
to be signiﬁcantly heritable (P0.05) indicating that variation in gene
expression was due to genetic differences among the strains. We found
that the expression of four genes namely Xrcc2, Axin2, Pcna andWnt16
was positively correlated with both ear wound healing and cartilage
regeneration. These genes represent two important biological processes
i.e. DNA repair and Wnt signaling, and therefore appear to have great
biological signiﬁcance in tissue regeneration. Wnt16 has been impli-
cated in cartilage regeneration in human while Xrcc2, Axin2 and Pcna
represent entirely new candidates.
Conclusions. These ﬁndings convincingly support the hypothesis that
similar biological pathwaysmight contribute to both ear wound healing
and articular cartilage regeneration and provide new candidate targets
for tissue regeneration studies.209
THE EFFECT OF LESION SIZE ON CLINICAL OUTCOMES AFTER
MICROFRACTURE: A 2 TO 8 YEAR FOLLOW-UP STUDY
K.K. Briggs, W.G. Rodkey, J. Steadman. Steadman Philippon Res. Inst., Vail,
CO, USA
Purpose: Microfracture is often the ﬁrst choice treatment for chondral
defects in the knee, but some studies have suggested outcomes are
inﬂuenced by lesion size at the time of the index surgery. Some authors
have suggested that microfracture is suitable only for lesions up to 200
mm2, and other authors have placed an upper size limit of 400 mm2 for
microfracture. The purpose of this study was to determine if there was
a relationship between the size of the cartilage lesion treated with the
appropriate microfracture surgical technique and rehabilitation proto-
cols and patient-centered outcomes. We hypothesized that at
a minimum of two years after microfracture patient-reported function,
activity level, and satisfaction with outcomes would be similar
regardless of the chondral lesion size at the time of index surgery.
Methods: An ethics board-approved clinical data registry was queried
for knees with contained focal chondral lesions and treated with
microfracture by a single surgeon. Six hundred ninety-two (692) knees
met the inclusion criteria. The lesions were on the femoral condyles, the
tibial plateaus, or in the patellofemoral joint. The size of the chondral
lesion was carefully measured and documented at the index surgery.
Patients were assigned to one of four groups based on lesion size: Group
I<100mm2, Group II 100-300mm2, Group III 301-400mm2, and Group
IV >400mm2. Previously published microfracture technique and reha-
bilitation protocols were used. Average follow-up was four (4) years
with a range of 2 to 8 years. The patient-centered outcomes measures
used for this study were the Lysholm function score, the Tegner activity
level scale, and patient satisfaction with outcomes where 0 ¼ totally
dissatisﬁed and 10 ¼ totally satisﬁed.
Results: At the latest follow-up, data were available as follows: Group I
contained 123 patients, Group II had 138, Group III included 161, and
Group IV contained 138 patients. Preoperatively, Groups I-III had an
average Lysholm score of 62, and Group IV had an average Lysholm
score of 50. At an average 4 years after the index microfracture proce-
dure (range, 2 to 8 years) with 80% (560 of 692) follow-up, there were
no signiﬁcant differences between groups for Lysholm, Tegner, or
patient satisfaction values (Table I). These ﬁndings were the same
regardless of lesion location (femur, tibia, or patellofemoral joint).
Conclusions: In this large group of patients with an average 4-year
follow-up, lesion size at the time of indexmicrofracture had no effect on
the patient-reported function (Lysholm), activity level (Tegner) or
patient satisfaction with outcomes. These results were consistent
regardless of lesion location. These ﬁndings conﬁrm our hypothesis that
patient-centered outcomes are the same for a contained chondral lesion
of the knee regardless of lesion size. With the proper surgical technique
and rehabilitation protocols, size of the lesion should not be a limitation
for the use of microfracture.
